TREM2 in neurodegeneration: Evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Rayaprolu, Sruti ^a   Mullen, Bianca ^a   Baker, Matt ^a   Lynch, Timothy ^b   Finger, Elizabeth ^c   Seeley, William W ^d   Hatanpaa, Kimmo J ^e   Lomen Hoerth, Catherine ^d   Kertesz, Andrew ^c   Bigio, Eileen H ^f   Lippa, Carol ^g   Josephs, Keith A ^h   Knopman, David S ^h   White, Charles L ^e   Caselli, Richard ⁱ   Mackenzie, Ian R ^j   Miller, Bruce L ^d   Boczarska Jedynak, Magdalena ^k   Opala, Grzegorz ^k   Krygowska Wajs, Anna ^l   Barcikowska, Maria ^m   Younkin, Steven G ^a   Petersen, Ronald C ^h   Ertekin Taner, Nilüfer ^a,n   Uitti, Ryan J ⁿ   Meschia, James F ⁿ   Boylan, Kevin B ⁿ   Boeve, Bradley F ^h   Graff Radford, Neill R ⁿ   Wszolek, Zbigniew K ⁿ   Dickson, Dennis W ^a   Rademakers, Rosa ^a   Ross, Owen A ^a   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c WESTERN UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h MAYO CLINIC   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k MEDICAL UNIVERSITY OF SILESIA   (Poland)

^l JAGIELLONIAN UNIVERSITY   (Poland)

^m MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

ⁿ MAYO CLINIC   (United States)

more..

Author keywords

Frontotemporal dementia; Genetic association; Parkinson disease; TREM2

Indexed keywords

MEMBRANE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC;

EID: 84879113935     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-19     Document Type: Article

References (19)

1. TREMs in the immune system and beyond. Colonna M, Nature reviews Immunology 2003 3 445 453 (Pubitemid 37339184)
2. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE, J Neurochem 2009 109 1144 1156
3. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, et al. Am J Hum Genet 2002 71 656 662 (Pubitemid 34970138)
4. Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for nasu-hakola disease. Thrash JC, Torbett BE, Carson MJ, Neurochem Res 2009 34 38 45
5. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. Guerreiro RJ, Lohmann E, Brás JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H, et al. JAMA neurology 2013 70 78 84
6. Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Chouery E, Delague V, Bergougnoux A, Koussa S, Serre J-L, Mé garbané A, Human mutation 2008 29 194 E204
7. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, Munoz C, Ramirez-Restrepo M, Gaiteri C, Myers AJ, et al. Neurobiology of Aging 2013 34 2077
8. Variant of TREM2 associated with the risk of Alzheimer's disease. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. The New England journal of medicine 2013 368 107 116
9. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T, Tran L, Dobrin R, et al. Cell 2013 153 707 720
10. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T, Tassi I, Takai T, Stanley SL, Miller M, et al. Nat Immunol 2009 10 734 743
11. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, Ruotsalainen V, Hakola P, Bakker AB, Phillips JH, Pekkarinen P, et al. Nat Genet 2000 25 357 361 (Pubitemid 30437329)
12. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, et al. Nat Genet 2012 44 200 205
13. Frontotemporal dementia: clinicopathological correlations. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, et al. Annals of neurology 2006 59 952 962 (Pubitemid 43830927)
14. Antemortem diagnosis of frontotemporal lobar degeneration. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, Josephs KA, Petersen RC, Annals of neurology 2005 57 480 488 (Pubitemid 40471156)
15. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, et al. Neurology 1998 51 1546 1554
16. Diagnostic criteria for parkinson disease. Gelb DJ, Oliver E, Gilman S, Arch Neurol 1999 56 33 39 (Pubitemid 29046907)
17. The ischemic stroke genetics study (ISGS) protocol. Meschia JF, Brott TG, Brown RD Jr, Crook RJ, Frankel M, Hardy J, Merino JG, Rich SS, Silliman S, Worrall BB, BMC Neurol 2003 3 4
18. Investigating the role of FUS exonic variants in essential tremor. Labbe C, Soto-Ortolaza AI, Rayaprolu S, Harriott AM, Strongosky AJ, Uitti RJ, Van Gerpen JA, Wszolek ZK, Ross OA, Parkinsonism Relat Disord 2013 19 755 757
19. PLINK: a tool set for whole-genome association and population-based linkage analyses. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, Am J Hum Genet 2007 81 559 575 (Pubitemid 47330214)